BridgeBio Pharma
BBIO
33,71 €
Share price
0.83%
Change (1 day)
18.11%
Change (1 year)
Categories
Revenue for BridgeBio Pharma (BBIO)
Revenue in 2024 (TTM): €0.20 Billion
According to BridgeBio Pharma
's latest financial reports the company's current revenue (TTM 
) is €0.20 Billion. an increase over the revenue in the year 2023 that were of €8.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BridgeBio Pharma from 2018 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €0.21 B | 2433.91% |
| 2023 | €8.41 M | -88.37% |
| 2022 | €72.38 M | 17.59% |
| 2021 | €61.55 M | 817.9% |
| 2020 | €6.7 M | -81.48% |
| 2019 | €36.2 M | |
| 2018 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €0.2 M | -99.90% | 🇺🇸 USA |
 | €0.66 B | 221.38% | 🇺🇸 USA |